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Summary 
 
The ability to directly uncover the contributions of genes to a given phenotype is 
fundamental for biology research. However, ostensibly homogeneous cell 
populations exhibit large clonal variance1,2 that can confound analyses and 
undermine reproducibility3. Here, we used genome-saturated mutagenesis to create 
a biobank of over 100,000 individual haploid murine embryonic stem cell (mESC) 
lines targeting 16,950 genes with genetically bar-coded, conditional and reversible 
mutations. This Haplobank is the largest resource of hemi-/homozygous mutant 
mESCs to date and  is available to all researchers. Reversible mutagenesis overcomes 
clonal variance by permitting functional annotation of the genome directly in sister 
cells. We utilize Haplobank in reverse genetic screens to investigate the temporal 
resolution of essential genes in mESCs, and to identify novel genes that control 
sprouting angiogenesis and blood vessel lineage specification. Further, a genome-
wide forward screen with Haplobank identified PLA2G16 as a host factor required for 
cytotoxicity by rhinoviruses, which cause the common cold. Thus, Haplobank clones 
and revertible technologies enable high-throughput, reproducible functional 
annotation of the genome. 
 
  
Approaches to functionally analyze the mammalian genome include ENU mutagenesis4, 
gene targeting5, RNA interference6,7, and CRISPR-mediated genome editing8. Although 
powerful, these approaches suffer from various caveats, such as poor knockdown 
efficiency and off-target effects9–11. Additionally, clonal variability within populations can 
compromise comparisons and reproducibility3,12,13,14. Thus, reversibile mutations 
enabling direct comparison of phenotypes within a single clone are pivotal to study 
genetic dependencies. 
 
To generate a conditional mutagenesis system at a genome-wide scale and at the clonal 
level, we applied insertional mutagenesis with genetically bar-coded lentiviral-, 
retroviral- 15,16 and transposon [Tol2 17 and Sleeping beauty (SB)18]-based vectors in 
haploid murine embryonic stem cells (mESCs, Fig. 1a), which enable recessive genetics. 
We analyzed several parthenogenic haploid mESC lines (129/Sv x C57/B6 background) 
(Extended Data Fig. 1a,b) and chose to pursue AN3-12 cells, which grow in feeder-free 
conditions and maintain a stable haploid genome across many generations in an 
undifferentiated state. These cells express pluripotency markers and differentiate into all 
germ layers in vivo (Extended Data Fig.1c-h). Importantly, AN3-12 cells display only 
minor genomic duplications and deletions, potentially affecting the genes Cdh4, Taf4a, 
Agmo, and Cox7c  (Extended Data Fig. 2). Insertional mutagenesis permits the integration 
of invertable splice acceptors, resulting in conditional alleles, as well as high-throughput 
direct identification of integration sites. To map insertion sites and complex internal bar-
codes (>107) by inverse PCR, an optimized universal sequencing strategy was established 
(Extended Data Fig. 3a,b). A combination of strategies was used to avoid genomic biases 
of the insertional mutagenesis systems (Fig. 1a,b; Extended Data Figs. 3c-f and 4a, 
reviewed in19,20), yielding genome-wide mutagenesis (Fig. 1c). Of note, Tol2 outperformed 
the classical viral delivery systems and even in silico mutagenesis at <1 million 
integrations (Fig. 1c). The mutagenesis systems also generated anti-sense and intergenic 
integrations at high frequency due to cryptic transcriptional start sites (Extended Data 
Fig. 4b,c), however this is not expected to affect disruption of transcription in sense 
oriantation. Thus, we utilized various delivery systems to obtain unbiased, genome-
saturated, and conditional mutagenesis. 
 Next, we developed a high-throughput pipeline to create a biobank of reversible 
mutations in AN3-12 haploid mESCs. Starting from haploid mESC pools that contained 
between 107-108 distinct mutations for each mutagen, we arrayed, processed, banked, 
and mapped over 100,000 individual mESC clones (Extended Data Fig. 4d-g). In total, we 
generated sense and anti-sense clones that target 16,970 of ~ 24,000 annotated mouse 
genes (genome release mm10), covering over 70% of the protein-coding genome 
(Supplementary Table 1 and Extended Data Fig. 5a-c). Integrations display a 5’ bias in 
genes and in coding sequence (Extended Data Fig. 5d), resulting in truncations that are 
likely to generate loss-of-function alleles. All pools of mutated cells are available at 
www.haplobank.at. This resource represents a comprehensive library of mESC clones 
carrying hemi/homozygous, twice reversible, bar-coded integrations, combining the 
power of stem cells with tunable mutagenesis.  
 
A key advantage of Haplobank is the ability to compare each mESC clone with its sister 
clone carrying the conditionally inverted splice acceptor. As a proof-of-principle, we 
analyzed two mESC clones containing sense integrations within Ctnna1, which encodes 
alphaE-catenin and is critical for mESC adhesion21. mESCs with sense integrations 
exhibited reduced Ctnna1 expression and impaired cell adhesion, which were both 
restored by FlpO-mediated reversal of the integrated mutagenesis vectors. Further, Cre-
mediated reversal back into the sense orientation again disrupted alphaE catenin-
mediated cell adhesion (Fig. 1d,e). Additionally, we evaluated mESC lines carrying non-
disruptive, anti-sense integrations in presumed essential genes. We infected these mESC 
lines with a pool of retroviruses that encode Cre and mCherry, or GFP only. If a gene is 
essential, Cre-mediated reversion of the integration to the disruptive sense orientation 
should specifically deplete mCherry+ cells from the mCherry+/GFP+ cell pool over time, as 
detected by flow cytometry. Indeed, we confirmed the essential role of several genes for 
mESC survival (Fig. 2a, b). Thus, our system allows for a direct functional annotation of 
essentiality, instead of screening for the absence of mutations; moreover, one can directly 
examine the penetrance and timing of lethal phenotypes. 
 Next, we performed a genome-wide screen to uncover novel hits for resistance against 
infection with a common cold virus. We chose the rhinovirus serotype RV-A1a, which 
replicates in mouse cells22.  A pool of mESCs carrying gene trap insertions was exposed to 
rhinovirus every other day for 3 weeks. The surviving, virus-resistant cells displayed an 
enrichment for multiple disruptive insertions in the low density lipoprotein receptor 
(Ldlr), a known entry portal for this virus (p-value=2.9*10-12), and in the phospholipase 
Pla2g16 (p-value=1.4*10-11) (Fig. 2c). We confirmed that these genes are required for 
viral killing using three different sister clones with revertible integrations (Fig. 2d). Next, 
we used CRISPR-Cas9 technology to disrupt these genes in human embryonic kidney 
(HEK293T) cells and monitored competitive proliferation with and without RV-A1a 
infection. In this assay, LDLR was not required for RV-A1a-mediated killing (Fig. 2e), 
presumably because the virus can enter via other receptors in the absence of functional 
LDLR in HEK293T cells23. Importantly, we confirmed that inactivation of PLA2G16 with 
different sgRNAs confers a selective survival advantage to HEK293T cells exposed to RV-
A1a (Fig. 2e). Thus, Haplobank enables genome-saturated forward screening and 
validation to discover novel genes underlying specific phenotypes. 
 
PLA2G16 can catalyze the rate limiting step of arachidonic acid synthesis, and thus 
couples to cyclooxygenases (COX) and prostaglandin synthesis24,25. However, different 
COX inhibitory drugs did not block RV-A1a-mediated cell death of control or repaired 
Pla2g16 sister mESCs, nor did arachidonic acid enhance RV-A1a toxicity (Extended Data 
Fig. 6a). Selective survival of Pla2g16 or Ldlr mutant mES cells was not affected by COX 
inhibitors (Extended Data Fig. 6b). Of note, the COX inhibitory drugs ibuprofen and 
indomethacin conferred partial resistance to RV-A1a in HEK293T cells (Extended Data 
Fig. 7a-c), albeit at concentrations that also affect other pathways26. Structurally, the short 
C-terminal vesicular domain of PLA2G16 extends into the endosomal lumen where the 
virion is located prior to releasing its RNA (Fig. 2f)27. To test the relevance of this domain, 
we edited the Pla2g16 coding region in the endosomal C-terminus and 3’UTR using 
CRISPR/Cas9 and selected for RV-A1a resistant cells. Mutations conferring resistance to 
RV-A1a were enriched in the transmembrane domain and the vesicular domains (Fig. 2f; 
Extended Data Fig. 7d-f), consistent with a recent, independent haploid screen that 
identified PLA2G16 in picorna viridae infection28. Our results identify the C-terminal 
domain of Pla2g16 is a target to block rhinoviral infections. 
 
As a third application of Haplobank, we investigated pathways required for 
angiogenesis29. Multiple candidate angiogenesis genes have been proposed, but few have 
been functionally validated30,31. We adapted embryoid body (EB) blood vessel sprouting, 
which recapitulates key features of in vivo angiogenesis32, to our haploid mESCs. Sprouts 
stained positive for the endothelial marker CD31 and the basal membrane protein 
collagen IV, and formed lumens (Fig. 3b). Similar to in vivo blood vessel formation, the 
cells fronting the vascular structures exhibited characteristic features of tip cells, such as 
CD31-positive filopodia protrusions followed by stalk cells (Fig. 3b). Tip cells express 
Delta like ligand 4 (Dll4), which activates the Notch1 pathway on stalk cells to suppress 
their conversion into tip cells33. We used Notch1 anti-sense non-disruptive clones from 
Haplobank and, via Cre recombination, created stable sister, sense clones that knock-out 
Notch1 expression (Extended Data Fig. 8a). EBs derived from multiple sense, knock-out 
sister clones displayed significantly increased vessel density (Extended Data Fig. 8b and 
not shown). Gene trap integration upstream of the Notch1 gene did not alter vessel 
density (Extended Data Fig. 8c). Thus, our EB sprouting assay recapitulates normal blood 
vessel development.  
 
To identify novel genes, we selected candidates that are more highly expressed in tip 
versus stalk cells30,31 and were associated with human vascular disease (Extended Data 
Fig. 8d). We focused on 32 genes,represented in Haplobank. To ensure that differences in 
angiogenesis are directly linked to inactivation of the respective target genes, and not 
genetic background noise or clonal effects, we performed color tracing. We infected 
selected mESCs with GFP- or mCherry-Cre expressing retroviruses to generate sister 
clones with reverted orientation of the integration (Fig. 3c). We observed large variability 
between independent clones (Extended Data Fig. 8e,f), highlighting the importance of 
comparing mutant to genetically repaired sister clones for each gene. Genetic inactivation 
of Myst3, Mecom, Gja1, Gabrb3, Tnfrsf1a, and Dlg2 reduced sprouting angiogenesis and 
decreased vessel formation at least 2-fold compared to anti-sense clones; gene trapping 
of Enpp3, Smarca1, Ndufs4, Plcb1, or Hck promoted blood vessel growth (Fig. 3d,e; 
Extended Data Fig. 9). Thus, Haplobank enabled rapid, functional and reproducible 
validation of candidate angiogenesis genes in engineered blood vessels.  
 
To assess the in vivo role of these novel angiogenesis genes, we generated EBs from mESCs 
stably expressing mCherry and injected them into immuno-compromised mice. The 
resulting teratomas were assessed for mESC-derived mCherry+ IB4+ blood vessels (Fig. 
4a, Extended Data Fig. 10a). To control for teratoma growth rates, we injected 1:1 mixed 
mosaic EBs of sense (mutant, GFP+) and their respective anti-sense clones (repaired, 
mCherry+). The contribution of GFP- or mCherry-expressing cells to the endothelial 
lineage as well as non-endothelial tissues was assessed by cytometry (Extended Data Fig. 
10b). Mutated clones of Myst3, Gja1 and Grin2b displayed a decreased contribution to IB4+ 
vasculature (Fig. 4a; Extended Data Fig. 10b). In contrast, mutant clones that showed 
increased vessel density in vitro exhibited a greater capacity to form blood vessels in vivo 
than their anti-sense sister clones (Fig. 4a). These data were confirmed using in situ blood 
vessel analysis of mixed teratomas (Fig. 4b). To test whether the identified genes 
modulate angiogenesis via specification of tip cell fate, we performed mosaic tip cell 
competition assays (Extended Data Fig. 10c,d). As a positive control, we assessed genetic 
modulation of the Notch1 pathway. As expected, mCherry+ (sense knock-out) Notch1 
mutant cells preferentially localized to the tip position compared to GFP+ anti-sense 
Notch1-expressing sister clones (Fig. 4c,d). Most clones carrying gene mutations that 
increased sprouting activity displayed a significant increase to the tip cell position, and 
vice versa (Fig. 4c-e). Therefore, the newly identified angiogenesis genes can control  the 
tip cell fate.  
 
We tested whether one of our novel angiogenesis  genes,  Gja1, encoding the gap junction 
protein Connexin43 34, is involved in physiological vascularization of the mouse retina, 
which begins at birth and progresses until postnatal day 7 35. At postnatal day 6, we 
observed high Gja1/Connexin43 expression at the angiogenic front where 
Gja1/Connexin43 localized to endothelial junctions, with the highest intensity in tip cells 
(Extended Data Fig. 10e). At the vascular plexus, Gja1/Connexin43 expression was 
predominantly detected in perivascular cells, not endothelial cells (Extended Data Fig. 
10f). Moreover, Gja1/Connexin43 was primarily detected at the tip of the developing 
vascular sprout in 3D blood vessels (Extended Data Fig. 10g). Newborn mice injected i.v. 
with a Gja1/Connexin43 blocking peptide displayed a delay in vascular network 
progression and complexity in the retina compared to those injected with a scrambled 
control peptide36 (Fig. 4f). The number of tip cells at the angiogenic front was decreased, 
together with decreased numbers of branch points in the vascular plexus (Fig. 4f). Thus, 
Gja1/Connexin43 is a key regulator of tip cell fate and physiological angiogenesis in vivo.  
 
In summary, the Haplobank resource contains over 100,000 individually mutagenized 
and bar-coded mESC lines targeting 16,970 protein coding genes. Haplobank 
complements a collection of 3,396 reversibley targeted genes in a near haploid human 
leukemia cell line45. Our proof-of-principle experiments uncovering genes required for 
rhinovirus infection and angiogenesis establish the power of Haplobank in forward and 
reverse genetic screens, respectively. The strong variability between independent clones 
revealed the importance of assessing mutant and repaired clones side-by-side, and 
addresses an increased demand for rigor and reproductibility37. Thus, Haplobank clones 
and revertible technologies enable high-throughput, reproducible functional annotation 
of the genome.  
 
  
Supplementary information is available in the online version of the paper.  
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Figure 1. A repairable mutant mES cell library.  
a) Schematic representation of insertional mutagenesis vectors: Splice acceptor sites (SA) 
are revertible using non-compatible loxP/lox5171 and FRT/F3 sites (triangles). G418 
resistance is conferred by beta-Geo (bgeo) transcribed from the revertible cassette (gene 
trap vectors, GT) or Neo independently from a PGK promoter (polyA trap, pA), stabilized 
by a splice donor (SD). Six osteopontin enhancer (OPE) elements (enhanced gene trap; 
Lenti-ETG, Retro-EGT, and Tol2-EGT vectors) enhance expression of beta-Geo via 
Oct4/Pouf51 binding. RetroRS carries a spacer sequence between loxP sites and lacks 
OPEs. Purple diamonds indicate internal barcodes (BC). LTR, long terminal repeats; 
L200/R175 and LITR/RITR, terminal repeats of Tol2 and SB. b) Heat map representing 
numbers of integrations per gene per 1 million integrations. Gene expression levels are 
shown (blue=highly expressed, white=not expressed). Color code shows numbers of 
integrations. c) Saturation of mutagenesis systems compared to random in silico 
mutagenesis. Y-axis, total numbers of insertions versus % of genes with integrations. d) 
Schematic representation of splice acceptor inversions. e) Loss of mESC adhesion in 
clones with integrations in intron 1 of Ctnna1. Inversion of the gene trap restores cell 
adhesion, subsequent reversion again disruptes adhesion. Phalloidin images polymerized 
actin; DAPI visualizes nuclei. Size bars, 10 µm. One representative experiment out of 2 
biological replicates is shown.  
 
 
Figure 2. Essential genes for mESC and common cold virus infections. 
a,b) Functional annotation of essential mESC genes. a) Competitive growth assays of anti-
sense (GFP+) and Cre-reverted sense (mCherry+) sister cells harboring integrations in the 
indicated genes. Cell populations were analyzed at the indicated days after Cre addition 
using flow cytometry. Means +/- SD of biological triplicates. b) FACS plots for the essential 
gene Psmd1 illustrating depletion of Cherry+ cells. c) Integration sites of top scoring genes 
in our haploid mESC survival screen of human rhinovirus RV-A1a infections. Loss of 
function score for integrations into the Ldlr locus p=2.9x1012 and p=1.4x1011 for Pla2g16. 
Sense integrations, red triangles; anti-sense integrations, green; exons, blue boxes. 
Transcriptional start sites are marked. d) Growth advantage of sense versus respective 
anti-sense sister mESC harboring integrations in Pla2g16 or Ldlr upon infection with RV-
A1a. In un-infected cells, mutation of these genes did not confer growth advantages; 
arbitrarily set to 1. e) Human embryonic kidney HEK293T cells were transduced with 4 
different sgRNAs against PLA2G16 and LDLR in biological triplicates, mixed with control 
GFP+ HEK293T cells at a ratio of 1:3. Ratios of control to mutated HEK293T cells were 
evaluated on day 13 after infection using FACS. Data in d and e are means +/- SD, 
normalized to uninfected cells. Individual data points and error bar (STDEV); one tailed 
students t-test, *< 0.1, **< 0.01, ***< 0.001. f) Targeting of the C-terminal Pla2g16 domain 
using CRISPR/Cas9. Upon selection of haploid cells to ensure hemizygous editing, cells 
were split and maintained in the presence and absence of RV-A1a.  
 
Figure 3. Novel regulators of angiogenesis.  
a, Generation of sprouting vasculature from haploid mESCs, differentiated into Embryoid 
Bodies (EBs) and cultured with VEGF-A (30ng/mL). b, CD31+ (green) endothelial cells and 
filopodia, indicative of tip cells in blood vessel sprouts. Luminal structures and Collagen 
IV+ basement membranes are shown in right panels. Scale bars, 200µm or as indicated. c, 
Schematic outline for functional validation of candidate genes in sprouting angiogenesis. 
Haplobank clones were infected with GFP or mCherry-Cre viruses to generate disruptive 
sense (S) and anti-sense (AS) sister cells. d, Representative images of hypo- and hyper-
sprouting sense (S) and anti-sense (AS) sister clones. IB4 marks endothelial cells. Scales, 
500µm. e, Quantification of IB4+ blood vessel sprouts. Data were normalized to the 
respective anti-sense sister clones. Means ± SEM are shown from a minimum of n=3 
independent experiments. *<0.05; **< 0.01; ***< 0.001 (Two tailed students t-test).  
 
 
Figure 4. In vivo angiogenesis and cell specifications.  
a, Quantification of the indicated sense and anti-sense targeted clones to form blood 
vessels in teratomas. Means ± SEM are shown (n=3 independent teratomas; n=5 for the 
AN3-12 control). *< 0.05 (Two tailed students t-test). b, Gja1-sense (GFP+) and Gja1-
antisense (mCherry+) sister mES cells were mixed 1:1 to form chimeric EBs and 
subsequently injected into immunocompromised nu/nu mice. Representative sections to 
identify IB4, GFP, and mCherry expressing cells are shown. Scale bar 50µm. c, Notch1 anti-
sense and mCherry-Cre+ Notch1-sense sister mES cells were mixed (1:1 ratio) to generate 
mosaic blood vessels and analyzed for red or green cells at the tip position. Scale bar 
200µm. d, Relative tip cell position of sister cells with sense and anti-sense integrations 
in the indicated genes, determined in chimeric 3D sprouts. Means ± SEM of a minimum of 
n=3 independent experiments. *< 0.05; **< 0.01; ***< 0.001 (Two tailed students t-test). 
e, Representative image of mosaic blood vessel sprouts from Gja1 sense and anti-sense 
sister clones. Scale bars, 500 µm and 100 µm (insert). f, Intravenous injection of a Gja1 
inhibitory peptide (GAP26) into neonatal mice abrogated retinal angiogenesis. At day 5 
after birth, retinas were isolated and stained for IB4+ blood vessels. Scale bars: 500µm 
upper, 100µm lower panels. 
  




Haploid ES cell cultures. The murine haploid ES cells used for this study are a feeder 
independent clonal derivative of HMSc2 termed AN3-12. Haploid ES cells were grown in 
standard ES cell medium with serum and LIF. Cell culture-grade dishes were from Greiner 
(15 cm dishes, 15cm Cellstar cell culture dishes, cat no 639160) and NUNC (all other formats, 
e.g. 10cm dish Nunclon ∆ Surface, cat no. 150350; 6-well Nunclon ∆ Surface, cat no. 140675). 
The following ES cell medium (ESCM) was used: 450 ml DMEM (Sigma D1152); 75 ml FCS 
(Invitrogen); 5.5 ml P/S (Sigma P0781); 5.5 ml NEAA (Sigma M7145); 5.5 ml LGlu (Sigma 
G7513); 5.5 ml NaPyr (Sigma S8636); 0.55 ml ME (Merck 805740; dilute 10 l bME in 2.85 
ml PBS for a 1000x stock); and ESGRO (Millipore ESG1107; used according to instructions by 
the manufacturer). For freezing, ES cell clones were expanded, harvested from a confluent 10 
cm dish by trypsinization, the reaction stopped with ESC medium, and subsequently the cells 
centrifuged at 1200 rpm for 5 min. Supernatants were discarded and cell pellets re-
suspended in 1 ml PBS. Twenty µl of the cell suspension were removed and used to prepare 
DNA for barcode and integration site PCR. Finally, 7 ml freezing medium was added (1 vol 
ESC medium, 1 vol FCS, 11% DMSO (Sigma # 41648)) and cells were frozen in quadruplicates 
in 2ml cryovials. Enzymatic Mycoplasma tests were performed on a weekly basis. For 
purification and maintenance, haploid cells were trypsinized and incubated in 10 g/ml 
Hoechst33342 (Sigma B2261) for 30-40min at 37˚C and subjected to FACS sorting using a BD 
AriaIII equipped with a near UV laser. For flow cytometric analysis cells were trypsinized and 
analyzed using a FACS BD LSRFortessa (BDBiosciences) equipped with a high throughput 
sampler. Data analysis was performed using FACS Diva and FlowJo. To generate single cell-
derived colonies, 200 cells/10cm dish were plated and grown for 10-11 days. Cells were 
washed once with PBS, and clones manually picked in 20 μl PBS under a binocular into 96U 
well plates (Nunc). The picked colonies were dispersed into single cells by incubation with 5 
μl 0.25% trypsin in 20 μl PBS for 6 min at 37oC. The reaction was stopped with 175 μl ESCM, 
and the cells were then split into 96F well plates, or directly into a 24 well dish for further 
analysis. For robot assisted picking, colonies were transferred in 20l PBS or DMEM in U-
well plates subsequent to picking into a Hamilton Lab Star. Cells were dissociated using 
trypsin as above and plated in 5 replicas using the 96 head pipetting block. Clones were 
expanded in 96 well plates for 3 days and frozen in matrix plates with 2D barcodes or in 
cryogenic vials (Thermo Scientific) and finally transferred to liquid nitrogen. A step-by step 
protocol describing haploid cell cultivation can be found at Protocol Exchange38 
 
Viral and transposon vectors for haploid ES cell mutagenesis. For retro- and lentiviral 
library generation, gene trap viruses carrying a neomycin resistance were packaged in 
PlatinumE (Cell Biolabs, used only at early passage after obtaining from vendor, tested for 
cell identity by antibiotics resistance and capability to package virus) or LentiX (Clontech, 
used only at early passage after obtaining from vendor,  further identified by capability to 
package virus) cells, respectively. For some experiments, virus was concentrated by 
centrifugation (25.000 rpm, 4°C, 4 hrs) and FACS sorted haploid ES cells were then infected 
for 8 hrs in the presence of 2μg polybrene per ml; 50 µM JQ1 was used to increase infection 
efficiency. For transposon based library generation, FACS-sorted haploid ES cells were 
nucleofected (Amaxa Nucleofector, program A13) using transposons containing gene trap 
cassettes carrying a splice acceptor, a RPB1 promoter and a neomycin resistance gene. Thirty 
hrs post infection, selection for gene trap insertions started using G418 (Gibco) at 0.2mg/ml. 
To estimate numbers of integrations and thus library complexity, 10,000 cells (for viruses) 
or 50,000 cells (for transposons) were plated on 15 cm dishes and selected using G418. For 
comparison, 1000 cells were plated but not exposed to G418 selection. On day 10, colonies 
were counted.  
 
4D pooling. In brief, up to hundred 96-well plates containing lysed cells were stacked into 
10 towers of 10 plates (i.e. slices) height. In the first step, lysates were pooled into “Master 
tower” plates containing pools of all plates within 1 tower and a fraction of lysate was 
separated into jars containing pools of all wells of each plate termed “slice”. While processing 
further towers, identical slices were united with previous ones and new master tower plates 
were generated. In a second run, master tower plates were pooled along rows and columns of 
96 well plates representing all wells within 1 tower. Finally, this resulted in 40 pools 
representative of 12 columns, 8 rows, 10 slices, and 10 towers. Lysate of each well were thus 
present in 4 coordinates. Upon DNA purification, the 40 individual pools were processed for 
inverse PCR adding individual indices to each pool in the PCR step. Subsequently, the pool of 
all coordinates was sequenced within one lane of an illumina sequencer. Two independent 
strategies of iPCR based on different restriction enzymes were used to identify mutations and 
coordinates. In addition, direct genomic PCR amplifying the internal barcodes of the 
mutagens was performed with the same experimental indices. For details see below.  
 
Parallel cloning of internal barcodes. All mutagenesis vectors were designed with highly 
complex barcodes (BC) for confirmation of the generated clones. The complex BC sequences 
were obtained as ultramers from ‘Integrated DNA Technologies’ as “PAGE Ultramer DNA 
Oligos” and contained 32 bp BC sequences flanked by BspEI and BstEII restriction sites. Two 
versions with either strong-weak (SW) or weak-strong (WS) alternating sequences were 
cloned into each frame; BC sequences were amplified by PCR and purified over columns 
(Qiagen). The gene trap vector plasmids (GT-MCS, frame 0/1/2) were digested with AgeI and 
BstEII and dephosphorylated. Fragments were separated by agarose gel electrophoresis, 
phenol extracted and precipitated with ethanol. Amplified BC-oligos were digested with 
BspEI and BstEII. Backbones and inserts were ligated with T4 DNA ligase (NEB) and 
electroporated (BioRad, Gene Pulser II) into appropriate electrocompetent cells. Bacteria 
were plated and grown over night and further expanded in liquid culture for 6h. Plasmid DNA 
extraction was performed using established protocols (Qiagen). The following barcode PCR 
primers were used: forward primer: GTTGATCTGAGCTACTCATCAACGGT; reverse: 
AAGTTCCTTCTGGTTCTGGCTCTGCT. Twenty µl of PCR reactions were analyzed on a 2 % 
agarose gel and PCR products were purified for sequencing using Illustra ExoStar 1 – step kit 
(GE Healthcare). For Sanger sequencing, the barcode PCR-reverse primer was used. 
 
Mapping of genomic integrations by next generation sequencing. Enzyme 1 (E1) was 
used to fragment the genome. As the recognition sequence for E1 is also present adjacent to 
the barcode of the gene trap vector, it is possible to retrieve the exact integration site of the 
gene trap cassette within the genome by circularizing E1-digested gDNA and subsequent 
amplification of the genomic region by inverse PCR (iPCR) using primers “US” and “DS”. To 
improve iPCR efficiency, a linearization step using E2 was introduced, which re-opens the 
rings generated previously. Two mapping strategies using enzymes E1 were implemented 
for each mutagenesis system. For protocol details and sequence information, please also see 
www.haplobank.at.  
Mutagenesis system Enzyme1 (E1) Enzyme2 (E2) Mapping Strategy 
Retroviruses NlaIII, MseI SbfI 5' 
Tol2 NlaIII, TaqI PacI 3' 
Lentiviruses NlaIII, TaqI PacI 5' 
 
The following illumina iPCR primer sequences were used: DS: 
AATGATACGGCGACCACCGAGATCTACACGAGCCAGAACCAGAAGGAACTTGAC 
US: CAAGCAGAAGACGGCATACGAGATINDEXGTGACTGGAGTTCAGACGTGTGCTCTTC 
INDEX = custom barcode, 4-8bps.  
 
For genomic DNA preparation, cell pellets were lysed in lysis buffer (10mM Tris-HCl pH 8.0, 
5mM EDTA, 100mM NaCl, 1% SDS, 1 mg/ml Proteinase K) and incubated at 55˚C overnight. 
RNAse A (Qiagen, 100mg/ml) was added at a ratio of 1:1000. After incubation for 1 hr at 37˚C 
two phenol/chloroform/isoamyl alcohol extractions and a chloroform/isoamyl alcohol 
extraction, using phase lock tubes (5Prime), were performed. Samples were then incubated 
over night at the digestion enzyme specific temperatures. Restriction digests were purified 
using a PCR Purification Kit (Qiagen) and Ring ligated using T4 DNA ligase (Roche Applied 
Science). The ring-ligation reaction was incubated over night at 16˚C, heat-inactivated at 65˚C 
for 15 min and linearized by adding 1 µl Enzyme2 for 2 hrs at 37˚C. The digest was again 
purified using a PCR Purification Kit (Qiagen). The eluate was then used for iPCR. Twenty µl 
sample were finally analyzed on an agarose gel and the remaining PCR products purified 
using a Gel Extraction Kit (Qiagen). Next generation sequencing (NGS) was performed on an 
illumina HiSeq2500 sequencer according to the manufacturers protocols. Sequencing 
primers used for the 1st read as well as the experimental indices in BC-PCR were custom-
made, other primers were standard illumina primers:  
 Retrovirus 1:1 mix (due to alternative processing of viral LTRs):  
GAGTGATTGACTACCCGTCAGCGGGGGTCTTTCA 
TGAGTGATTGACTACCCACGACGGGGGTCTTTCA 
 Tol2: CACTTGAGTAAAATTTTTGAGTACTTTTTACACCTCTG 
 Lentivirus: CAGACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA 
 
To additionally confirm the genomic integration site of the gene trap cassettes, gene specific 
primers flanking the mapped locus were paired with mutagen specific primers to confirm 
integration as well as absence of the wild type allele. Integration site-specific primers were 
designed using Clone Manager 9 software (Sci-Ed Software). For each integration site, 4 PCR 
reactions with respective primer combinations (integration site-specific forward and reverse 
primer and integration site specific forward or reverse with mutagen-specific forward or 








4D deconvolution of NGS reads. Based on the restriction enzyme used for genome 
digestion, the 1st read was cut at the first restriction site if present within the 50bp of mapped 
sequence. A minimal length of 15nt was required. The sequence was aligned with bowtie 
against the mm10 genome39. A maximum of 1 mismatch (-v 1) was allowed. Only unique 
alignments (-m 1) in the best strata are reported. The 2nd read reading out the internal 
barcode was trimmed after 32nt. The alignment/internal barcode pairs were assigned to a 
defined well via the experimental indices. A valid assignment required a minimal count of 3 
per coordinate and a minimal fraction of 0.75 over alternative coordinates. The internal 
barcodes were merged with 4D pooling data if its count was higher than 20. This strategy 
was also used to verify the existing coordinates and uncover missing coordinates and/or 
additional integrations. Mapped insertions were intersected with the annotation (Ensembl) 
of all gene features including the intergenic region using BEDtools40. In silico insertions were 
randomly sampled from the mouse genome and aligned back to the genome.  
 
Chromosome spreads and FISH. Metaphase chromosomes were collected according to 
standard protocols. For multiplex-fluorescence in situ hybridization (M-FISH), Mouse 21-
color painting probe was made following the pooling strategy [2]). The M-FISH probe was 
denatured at 65°C for 10 min before being applied onto the denatured slides. The 
hybridization area was sealed with a 22 x 22-mm coverslip and rubber cement. Hybridization 
was carried out in a 37°C incubator for 2 nights. The post hybridization washes included a 5-
min stringent wash in 0.5x SSC at 75°C, followed by a 5-min rinse in 2 x SSC containing 0.05% 
Tween20 (VWR) and a 2-min rinse in 1x PBS, both at room temperature. Finally, slides were 
mounted with SlowFade Gold mounting solution containing 4’6-diamidino-2-phenylindole 
(DAPI, Invitrogen). Images were visualized on a Zeiss AxioImager D1 fluorescent microscope 
equipped with narrow band-pass filters for DAPI, DEAC, FITC, CY3, TEXAS RED, and CY5 
fluorescence and an ORCA-EA CCD camera (Hamamatsu). M-FISH digital images were 
captured using the SmartCapture software (Digital Scientific UK) and processed using the 
SmartType Karyotyper software (Digital Scientific UK). Approximately 200 metaphases from 
AN3-12 were counted for the diploid vs. haploid frequency and 10 well-spread metaphases 
were fully karyotyped by M-FISH and DAPI-banding pattern41. 
 
CNV analysis. Discriminative coverage analysis was performed to identify differences 
between genotypes in the number of copies of a genomic region as previously described 
(PMID:22136931). In brief, reads from 129, AN312 and C57BL/6J samples were aligned 
against the mm10 C57BL/6J mouse reference genome using bowtie v1.2 with parameters "-
v 3 -m 1 --best --strata". Coverage in non-overlapping 10k windows over the whole genome 
was calculated using bedtools (v2.26.0) makewindows and multicov (PMID:20110278). Read 
counts were scaled by library size and for each sample windows with extreme outlier counts 
were removed. 
 
SNP mapping. Variants were called with GATK v3.7-0 (PMID: 20644199) following 
established best practices. In brief, reads were aligned to the mm10 C57BL/6J mouse 
reference genome using bwa mem (bwa v0.7.12), duplicate reads were marked using Picard 
v2.6.0, reads were locally realigned around indels, base quality recalibration was performed 
using mm10 dbSNP as a training set, variants were called using HaplotypeCaller with ploidy 
set to 1 for AN312 and 2 for C57BL/6J and 129 samples, and variant filtration was applied 
according to GATK guidelines. For each sample, homozygous SNPs were counted in 
nonoverlapping 10-kb sliding windows and counts were plotted to estimate the distribution 
SNP densities on the mm10 reference genome.  
 
RNAseq. Reads were screened for ribosomal RNA by aligning with BWA (v0.6.1)42 against 
known rRNA sequences (RefSeq). The rRNA subtracted reads were aligned with TopHat 
(v1.4.1)43 against the Mus musculus genome (mm10); a maximum of 6 mismatches were 
allowed. Maximum multi-hits were set to 1 and InDels as well as Microexon-search was 
enabled. Additionally, a gene model was provided as GTF (UCSC RefSeq mm10). rRNA loci 
were masked on the genome for downstream analysis. Aligned reads were subjected to FPKM 
measurements with Cufflinks (v1.3.0)44,45. Furthermore, only those fragments compatible 
with UCSC RefSeq annotation (mm10) of genes with at least one protein coding transcript 
were allowed and counted towards the number of mapped hits used in the FPKM 
denominator. The mean FPKM was calculated over the replicates. 
 
Chromatin-IP. ChIP was essentially performed as described previously46. Briefly, after 
trypsinization, 25 million haploid ES cells were washed once in PBS before fixation for 7 min 
at room temperature by addition of formaldehyde to a final concentration of 1%. Crosslinking 
was quenched by addition of 2.5 M glycine (0.125 M final concentration) and cells were then 
incubated on ice. Crosslinked cells were spun at 600 g for 5 min and nuclei prepared by 
consecutive washes with Rinse 1 buffer (final: 50 mM HEPES pH 8.0, 140 mM NaCl, 10% 
glycerol, 0.5% NP40, 0.25% Triton X100, 1 mM EDTA) followed by Rinse 2 buffer (final: 10 
mM Tris pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 200 mM NaCl). Nuclei were re-suspended in 2 ml 
total volume of sonication buffer (0.1% SDS, 1mM EDTA, pH 8, 10mM Tris HCl, pH 8 with 
protease inhibitors complete mini (Roche)) and then sonicated with a Covaris E22 sonicator 
(Covaris settings: 5 % duty cycle, PIP 140, 200cyles/ burst, 15 min). ChIP was performed at 
4 degrees in ChIP buffer (final: 50 mM HEPES/KOH pH 7.5, 300 mM NaCl, 1 mM EDTA, 1 % 
Triton X100, 0.1 % DOC, 0.1% SDS) with the indicated antibody. Precipitated chromatin was 
purified using Dynabeads Protein G (Thermofisher, 10003D).  
 
ATACseq. ATACseq was performed as reported previously47. Briefly, 50,000 cells were 
washed on cold PBS before gentle resuspension in 50 l of cold lysis buffer (10 Mm Tris-HCl 
pH 7.4, 10mM NaCl, 3 mM MgCl2, 0.1% Igepal CA-630). For transposition reaction, nuclei 
were collected by immediate centrifugation for 15 min at 4oC. Supernatant was removed and 
nuclei were suspended in 50 l of transposition reaction mixture (25 μl 2x TD buffer (Nextera 
kit), 2.5 μL TDE1 (Nextera Tn5 Transposes), 22.5 μL nuclease-free water). Transposition 
reaction was performed at 37oC for 30 minutes followed by DNA purification using Qiagen 
MinElute Kit.  
 
5’RACE. 10 g of total RNA was isolated from ES cells using Trizol (Thermo Fisher Scientific), 
followed by additional purification and DNAse treatment with QIAGEN RNeasy mini kit. Poly-
A mRNA was enriched using dT(25)-Dynabeads (Thermo Fisher Scientific) using 
manufacturers recommendations. Purified mRNA was reverse transcribed with Super Script 
II polymerase (Invitrogen) in the presence of random hexamer primers using the following 
incubation protocol: 250C – 10min, 420C – 50min, 500C – 10min, 700C – 15min. cDNA from 
the reaction was purified with MinElute reaction clean-up kit (QIAGEN) and tailed with 
dCTPs using Terminal Transferase (NEB). 1/10 of the reaction was used for the first round 
of PCR with dG-anchor-primer/g.s.-outer-primer: 960C – 2min, (960C -15s; 600C – 15s; 680C 
– 3min)x23, 720C – 10min. Reaction products were diluted 10 X and used for the second 
round of PCR with dG-sec-anchor /g.s.-inner-primera with following incubation protocol: 
960C – 2min, (960C -15s; 630C – 15s; 720C – 3min)x23, 720C – 10min. Reaction products were 
purified with MinElute clean-up kit and cloned into a pJet1.2 vector (Thermo Fisher 
Scientific). Bacterial colonies were picked and sequenced with beta-geo_R4 primer. The 
following primers were used:  
g.s.-inner-primer 737 GTATCGGCCTCAGGAAGATCG 
g.s.-outer-primer 738 GCATCGTAACCGTGCATCTG 




beta-geo_R4 516 TCAGGCTGCGCAACTGTTGG 
 
Differentiation of parthenogenetic ES cell clones. ES cells were dissociated using trypsin 
and EB formation was induced using the hanging drop technique (1000cells/20uL drop) in 
ES cell media without LIF. After 3 days, the EBs were collected and transferred to non-treated 
petri dishes for further differentiation. On day 5 and day 12, EBs were harvested and RNA 
was isolated using TRIzol Reagent (Invitrogen) according to the manufacturers protocol. 1µg 
RNA was reverse transcribed into cDNA using the iScript cDNA Synthesis Kit (Bio-Rad). 
Subsequently, qRT-PCR was performed with the GoTaq qPCR Master Mix (Promega, A6001) 
using a Bio-Rad CFX384 Connect Real-Time PCR Detection System. The following primers (5’ 
-> 3’) were used for qRT-PCR: 
Oct4: FWD CCTACAGCAGATCACTCACATCGCC 
REV CCTGTAGCCTCATACTCTTCTCGTTGG 
Klf4: FWD GTGCCCCGACTAACCGTTG 
REV GTCGTTGAACTCCTCGGTCT 
Nanog: FWD CAGGAGTTTGAGGGTAGCTC 
REV CGGTTCATCATGGTACAGTC 
Keratin 18: FWD TTGCCGCCGATGACTTTAGA 
REV GGATGTCGCTCTCCACAGAC 
Nkx2-5: FWD CCCAAGTGCTCTCCTGCTTT 
REV TTTTTATCCGCCCGAGGGTC 
Sox17: FWD GAATCCAACCAGCCCACTGA 
REV TAGGGAAGACCCATCTCGGG 
 
To assess protein expression of pluripotency genes during differentiation, the haploid ESCs 
were cultured in ES cell Media without LIF in the presence of 500nM all trans-Retinoic acid 
(Sigma, R2625) and the media was replaced every other day. At indicated time points the 
cells were fixed in 4% PFA and stained for Oct4 (BD Bioscience, 611202), Nanog (R&D 
Systems, AF2729) and Sox2 (R&D Systems, AF2018), counterstained with DAPI and imaged 
with a Zeiss LSM 780.  
 
DNA content analysis and growth curves. Haploid AN3-12 cells were routinely passaged 
and fixed at indicated time points in ice cold 85% Ethanol and stored at -20. For analysis of 
DNA content, cells were stained with 10g/mL Hoechst33342 (Sigma B2261) for 30min on 
ice, washed and analysed on a BD Fortessa.  Viable cells were counted using a Countess II FL 
(Thermo Fisher) according to the manufacturer’s protocol. 
 
Keratinocyte differentiation. Embryoid bodies (EBs) from 2000 cells were generated using 
the hanging drop technique. After 3 days, 30-50 EBs were transferred to an Ultra-Low 
attachment 6 well plate and stimulated with 1μM retinoic acid for 3 more days. Next, EBs 
were transferred onto CollagenIV-coated dishes in ESCM without LIF medium supplemented 
with 25ng/ml hBMP-4 (R&D Systems). After 3 more days, the cells were incubated with CnT-
07 keratinocyte medium (CELLnTEC) and cultured for 6 more days. Keratin14 positive cell 
population was enriched by using the rapid adherence to CollagenIV: trypsinized cells 
(0.25% Trypsin-EDTA) were plated onto CollagenIV-coated wells and non-adherent cells 
were washed off after 15min incubation at room temperature.  
 
Reversion of gene trap cassettes. To reverse gene trap cassettes, ES cells were either stably 
infected or transiently transfected cells with a Cre- or Flpo-expressing plasmid also 
containing a fluorescent marker, e.g. EGFP or DsRed, using Lipofectamine 2000 (Invitrogen), 
Amaxa nucleofector (program A-13), or viral delivery as outlined above. If single cell derived 
clones were desired, cells were FACS-sorted for Cherry+ or GFP+ cells 24-48h post 
lipofection/nucleofection and 1000 cells were then seeded on 15 cm tissue culture dishes. On 
day 10 post sorting, colonies were picked and used for further analysis. For stable integration 
of Cre and the color marker upon infection, PlatinumE cells (Cell Biolabs) were transfected 
with the respective plasmids and ES cells subsequently infected. 30h post infection, cells 
were puromycin selected for further 72 hours. As controls, GFP-puro infected cells were 
selected and used. Inversion of the splice acceptor was determined by PCR on genomic DNA.  
The PCR was performed with three primers on ES cell lysates. Dependent on the 
orientation, either a fragment binding the 1st forward primer or a fragment binding the 
inverse forward primer were amplified. Upon first inversion, PCR fragments are larger in 
length. The second inversion results in a size reduction below the original orientation. The  
fo l lowin g specific PCR primers were used for Retro, Lenti, Tol2-EGT: EGT 1st fwd: 
CGACCTCGAGTACCACCACACT; EGT inv fwd: AAACGACGGGATCCGCCATGTCA; EGT com rev: 
TATCCAGCCCTCACTCCTTCTCT. Expected bands for Retro, Lenti, Tol2-EGT are: EGT 1st 
fwd/GT com rev: 343bps; EGT inv fwd/GT com rev: 443bps. The PCR primers for Tol2-pA 
were: Tol2 1st fwd: TGGGTTCAAGCGATTCTCCTGCCTCA; Tol2 inv fwd: 
AGATAGGCACCCAGGGTGATGCAAGCTC; Tol2 com rev: CCGATCCATCCATCGCATATTTGGGA. 
Expected bands for Tol2-pA: polyA trap 1st fwd /GT com rev: 326bps; polyA trap inv fwd/GT 
com rev: 439bps.  
 
RV-A1a infections. For virus production, Hela, cells at a confluency of 70-80%, were washed 
with PBS and infected with RV-A1a in infection medium (DMEM, 2% heat inactivated FCS, 
1% Penicillin/Streptomycin, 1% L-glutamine, 30mM MgCl2). After an incubation for 24 hrs, 
the virus was released from the cells by three freeze/thawing cycles and subsequently 
cellular debris was removed by centrifugation and filtration (4,000 rpm for 10 min at 4°C). 
For the genome-wide screen, retrovirally mutagenized haploid ES cells were seeded in 15cm 
dishes (1x107 cells per dish), and 5 hrs post seeding cells were infected with RV-A1a at a MIO 
of 5 in a 1:1 mixture of Hela infection medium:ESCM (MgCl2 and LiF were additionally added 
to balance the concentrations). For control mock infections, the Hela infection medium/ESCM 
mixture was used. On day 21 post infection, cells were pooled, and further processed for 
isolation of genomic DNA or frozen. Validation in ES cells was done using Haplobank clones 
(Ldlr: clone 1=238F02, clone 2=374A09, clone 3=1031A04; Pla2G16: clone 1=371H01, clone 
2=588G11, clone 3 = 917E06). HEK293T cells from an institute resource were tested for 
neomycin resistence to confirm cell identity. They were infected with GFP, empty guide, and 
Cas9 containing control, or puro selection marker, guide and Cas9 containing control vectors. 
Subsequent to selection, CRISPR/Cas9 edited cells were mixed with GFP positive cells. These 
cell mixtures were monitored in the presence and absence of RV-A1a for shifts in ratios of 
GFP expressing cells using FACS (BD LSRFortessa and FlowJo). Arachidonic acid, 
Acetylsalicylic acid, Ibuprofen, Indomethacin, Diclofenac, and Celecoxib (all from Sigma 
Aldrich) in DMSO were added to the cells 2h prior to RV-A1a infection at the indicated 
concentrations.  For interaction studies with Pla2g16 and Ldlr in mouse ES cells, the 
following drugs were used: Acetylsalicylic acid: 1mM, Archidonic acid: 10M, Celecoxib: 
nM, Diclofenac: 380nM, DMSO (vehicle): 0.1%, Ibuprofen: 72M, Indomethacin: 10M. 
The following guide sequences were used for mutagenesis:  
GFP sg GAGCTGGACGGCGACGTAAA 
LDLR sg1 TCAGACCGGGACTGCTTGGA 
LDLR sg2 CTGTTGCACTGGAAGCTGGC 
LDLR sg3 GCTGTTGCACTGGAAGCTGG 
LDLR sg4 GGAGCTGTTGCACTGGAAGC 
PLA2G16 sg1 GAAGGAATTGCTGTATGATG 
PLA2G16 sg2 CCTGCAGCAAAATCATCCAG 
PLA2G16 sg3 CTATGTTGGCGATGGATATG 
PLA2G16 sg4 CGCTGGATGATTTTGCTGCA 
Pla2g16 sgRNA1: TTGCTTCTGTTTCTTGTTTC 
Pla2g16 sgRNA2: CTGAATGACTGCCCAGTTTT 
 
Blood vessel sprouting assays. ES cells were trypsinized and seeded at 9600 cells/EB in a 
96 well low attachment plate (Sumitomo Bakelite, Prime Surface-U). After incubation for 14 
days in ESC Media without LIF in the presence of puromycin, the EBs were washed in ESC 
w/o LIF Media, embedded in 3D Collagen I gels and stimulated with 50 ng/mL VEGF-A (in 
house production) as previously described32. The first vascular outgrowth was observed 
after around 7 days and capillary like networks were analyzed 2 weeks after initial 
embedding of the EBs into the Collagen I matrix. For tip cell competition assays, mosaic EBs 
were generated from GFP and mCherry-Cre positive haploid ES cells. Briefly, Haploid ES cells 
were infected with viral supernatants harvested from Plat-E cells expressing GFP-Puro or 
mCherry-Cre-Puro. 48 hours after infection the cells were treated with 1 0µg/mL puromycin 
(Invivogen) to select for infected cells. Infected cells were FACS sorted for the 5% highest 
GFP/mCherry expressing cells, constantly kept under puromycin selection pressure to avoid 
reporter silencing, and then mixed at a 1:1 ratio to generate mosaic EBs. The following clones 
from the Haplobank were used to generate blood vessel organoids: Myst3  00235|A10; Myst3 
00564|C06; Prkcz  00355|E11; Syt16  00160|B12; Tesc  00279|B08; Gfod1 00284|F11; 
Enpp3 00455|E06; Enpp3 00584|E08; Enpp3 00535|F07; Grin2b 00335|G12; Grin2b 
00858|G05; Plcb1 00362|H01; Plcb1 00367|H09; Ndufs4 00318|D02; Ndufs4 10132|G01; 
Gja1 00345|A03; Tfpi 00281|H03; F2r 00351|E05; Pcsk6 00200|D09; Abcg2 00385|H12; 
Prkch 00102|C03; Igfr1 00535|B11; Entpd1 00588|B04; F3 00451|B01; Igf1 00455|D06; 
Plaur 00582|C11; Hckl 00449|E02; Mapt 00569|D06; Dlg2 00339|A01; Tnfrsf1a 00112|H07; 
Smarca1 00182|D04; Cdh13 00255|G04; Ets2 00341|E06; Tgfbr2 00583|D04; Gabrb3 
00578|B04; Abcb1a 00500|A06; Bag3 00338|G02. 
 
Immunofluorescence. To visualize the vascular outgrowths, blood vessels were fixed with 
4 % PFA for 20 min at room temperature and blocked with 3 % FBS, 1 % BSA, 0.5%Triton, 
and 0.5% Tween for 2 hrs. Biotinylated GSL Isolectin B4 (IB4; Vectorlabs 1201), anti-CD31 
(BD Pharmingen AB9498), and anti-Collagen IV (Millipore AB765P) were applied over night 
at 4°C. After washing with PBS-T (0.05 % Tween), the organoids were incubated with 
streptavidin-Alexa488, anti-rat-Alexa488, or anti-rabbit-Alexa647 secondary antibodies. 
Before mounting with DAKO mounting media under a stereomicroscope, organoids were 
subjected to 1 g/mL DAPI solution to image nuclei. A Zeiss LSM 780 was used to image the 
entire vascular outgrowth of every single organoid using tile scanning option and recording 
of z-stacks.  
 
Confirmation of Notch1 gene trap flipping by PCR and Western blot. DNA of stably GFP 
or mCherry-Cre infected cells was isolated using Phenol:Choloroform:isoamyl alcohol 
(25:24:1) (Sigma Aldrich) and Phase Lock Gel Heavy tubes (5prime). The following primer 
sequences were used for PCR: F1st: CTTCTGAGACGGAAAGAACCAGC, Finv: 
AAACGACGGGATCCGCCATGTCA Rev: TATCCAGCCCTCACTCCTTCTCT. The pair F1st+Rev 
amplifies a fragment of the original, unflipped gene trap and Finv+Rev amplifies the Cre 
recombined, flipped gene trap fragment. Western Blotting was performed using standard 
protocols. Blotted membranes were blocked in 3%BSA and subsequently incubated with 
antibodies to detect cleaved Notch1 (CST D3B8) and -actin (Sigma A5316) over-night. After 
washing in TBS-T (0.1%Tween) and incubating with HRP-linked secondary antibodies, blots 
were incubated in ECL solution (Pierce) for visualization.  
 
Teratoma assays. ES cells were dissociated and resuspended in growth factor reduced 
Matrigel (Corning, 356231) and kept on ice. 106 cells were injected into both flanks of 8-12 
weeks old MF1 nu/nu mice. Both, female and male mice were used.  For generation of a 
chimaeric vasculature, 2x106 ES cells were cultured in the presence of puromycin to avoid 
reporter silencing, in 15cm Petri dishes and mosaic EBs (GFP:mCherry 1:1) were generated. 
After 8 days of cultivation, the EBs were washed, resuspended in 200ml growth factor 
reduced Matrigel (BD 356231), and injected subcutaneously into the flanks of 
immunocompromised MF1 nu/nu mice using a 18G needle. Teratomas were analyzed 3-4 
weeks after injection. To this end, teratomas were either processed for 
immunohistochemistry or cells were isolated for FACS analysis. H&E slides were reviewed 
with a Zeiss Axioskop 2 MOT microscope (Carl Zeiss Microscopy) and subsequently digitized 
with the Pannoramic Flash III (Adimec-Q-12-A-180Fc camera) automated slide scanner (3D 
Histech). For immunohistochemistry, teratomas were fixed with 4 %PFA over-night and 
subsequently incubated in 20 % sucrose for around 24 hrs before embedding into O.C.T and 
processing the tissue to 60-80mm thick sections using a cryostat. For visualization, sections 
were incubated with anti-GFP (Abcam, AB111258), anti-mCherry (Abcam, AB125096), and 
biotinylated-IB4 (Vectorlabs, #1201) over night. After washing and incubation with anti-
goat-Alexa488, anti-mouse-Alexa555 and streptavidin-Alexa633, respectively, the 
specimens were imaged using a Zeiss LSM780 microscope. For FACS analysis, teratomas 
were cut into 1mm pieces and subjected to enzymatic digestion (Collagenase Type IV 
300U/mL, Worthingon; Dispase 0.25U/mL, Gibco; DNAse 7.5 /mL, Qiagen). Following a 1 
hr incubation at 37°C on a shaker, the cell suspension was pipetted through a 70 m cell 
strainer, washed 1x with DMEM before centrifugation at 400 x g for 10 min. Single cells were 
incubated for 45min with an anti-mouse VE-Cadherin-APC antibody (ebioscience 17-1441-
80) on ice. A ten min DAPI wash was performed to exclude dead cells from the FACS analysis. 
All animal studies were approved according to Austrian and EU legislature.  
 
Retina analyses. Retinas were harvested and prepared from mice as previously described35. 
The Gja1/Connexin43 inhibitory peptide (GAP26 - VCYDKSFPISHVR) and the scrambled 
control peptide (sGAP26-YSIVCKPHVFDRS) were synthesized by PSL GmbH, Germany) and 
injected i.v. in neonatal C57BL/6 mice as previously described36,48 at 2g/mouse. Whole 
mount retinas were immunostained for IB4 (Vectorlabs, #1201) or Gja1/Connexin43 (abcam 
AB11370) expression, incubated with the appropriate secondary antibodies (see above), and 
imaged using a LSM 780 microscope.  
Statistics. All values in the paper are means  SEM or SD. Comparisons between groups were 
made by Student’s t-test or 2-way ANOVA using GraphPad Prism (GraphPad Software, San 
Diego, CA) or R statistical software. No statistical methods were used to predetermine sample 
size. The experiments were not randomized and the investigators were not blinded to 
allocation during experiments and outcome assessment. P  0.05 was accepted as statistically 
significant. 
 
Data availability.  All genomic data have been deposited to NCBI Expression Omnibus and 
are accessible through the GEO accession number GSE84090 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=qrgxmuaindmpjah&acc=GSE8409
0). All material, protocols and cell lines can be obtained via the website www.haplobank.at 
as well as via Nature Protocol Exchange (Haplobank methods collection). 
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Extended Data Figure legends 
 
Extended Data Figure 1. Stem cell properties of the haploid subclone AN3-
12.  
e-f, Various parthenogenic cell lines derived from independent embryos from an outcross of 
129/Sv and C57/B6 and thus containing different genomic background on different 
chromosomes were subjected to embryoid body formation by placing 1000 cells/hanging 
drop. We observed downregulation of pluripotency marker genes (a) and upregulation of 
markers from all three germ layers (b) in all cell lines assayed on day 0 (d0), day 5 (d5) and 
day 12 (d12). The HMSc2 subclone AN3-12 was chosen for further study based on its growth 
properties in serum/LIF and absence of feeders. Data is shown as individual data points of 
n=2 technical replicates together the mean ± SD of one representative experiment. c, Growth 
curve of AN3-12 in the presence and absence of LIF. Data are shown as individual data points 
and mean values of 3 biological replicates ± SD.  d, FACS analysis of chromosome content of 
AN3-12 cells (in LIF, same experiment as shown in panel c) shows the decline of haploid (1n) 
from 35.5% to 24.9% during the 7day culture period. e, AN3-12 cells, cultured as in panel c, 
maintain a robust haploid population when analyzed on day 17 in ES cell medium despite 
rapid proliferation. f, Differentiation of AN3-12 cells into keratinocytes resulted in a near 
complete loss of haploid cells among the Keratin 14 (K14) positive population; ES cells 
stained with anti-K14 are shown as a negative specificity control (grey curve in the K14 
histogram). g, Immunostaining of AN3-12 cells cultured in ES cell medium as well as time 
course of removal of LIF with addition of 500nM retinoic acid (analysed on the indicated 
days) shows downregulation of pluripotency markers Oct4, Nanog, as well as Sox2. DAPI is 
shown as a nuclear counterstain. Bar graphs 50m h, Histological examination of Teratomas 
analysed 25 days after injection of 106 cells subcutaneously. All three germ layers were 
present in 6 analyzed teratomas, representative H&E images are shown. Magnifications are 
indicated in each panel.  
 
Extended Data Figure 2. Analysis of genome integrity. 
a, M-FISH karyotypic analysis was performed on parental mouse haploid cells (AN3-12) to 
evaluate genomic stability. Randomly selected metaphases were karyotyped and examined 
by M-FISH and DAPI banding. Approximately, 200 metaphases from AN3-12 were counted 
for the diploid versus haploid frequency and 10 well-spread metaphases were fully 
karyotyped by M-FISH and DAPI-banding pattern. Images of a normal female diploid and 
haploid karyotype [19, X] are shown. Images were captured on a Zeiss AxioImager D1 
fluorescent microscope equipped with narrow band-pass filters for DAPI, DEAC, FITC, CY3, 
TEXAS RED, and CY5. b, CNV (copy number variation) analysis of haploid AN3-13 cells by 
genome sequencing using IlluminaHiSeq2500. Mapped reads were analyzed relative to male 
genomes of parental mouse strains C57BL/6J and 129/Sv respectively, quotient to closer 
parental strain is shown. As expected, the X chromosome is overrepresented while the Y 
chromosome is absent. Regions of detected variation are highlighted with red boxes and 
shown below. Chromosome numbers are indicated. c, In AN3-12 haploid ES cells three very 
small deletions (on chromosomes 2, 10, and 12) and 1 duplication (on chromosome 13) were 
detectable as highlighted. d, Chromosomal distribution of SNP densities for in-house 129/SV 
and AN3-12 ES cells relative to in-house C57BL/6 are shown. Numbers of SNPs were 
calculated for all non-overlapping 100 kb windows across the mm10 C57BL/6J mouse 
reference genome. SNP density in AN3-12 shows regions of high and low number of SNPs 
relative to the C57BL/6J genome, as expected for a haploid cell line derived from an F1 female 
between 129/SV and C57BL/6.  
 
 
Extended Data Figure 3. Molecular characterization of mutagenesis 
vectors. 
a, Schematic illustration of the universal NGS sequencing strategy. Optimized primer binding 
sites compatible with Illumina sequencing and 2 restriction enzymes with 4 base pair 
recognition sites were placed adjacent to the terminal elements (LTR, TR). An internal 
barcode of 32 bases with alternating weak and strong bases was inserted in a parallel cloning 
step. b, For mapping of integration sites, genomic DNA was amplified by inverse PCR to 
introduce adaptor sequences and the experimental index for NGS. Paired-end sequencing 
maps the genomic integration in the first read using a custom primer, the experimental index 
as well as the internal barcode using standard Illumina primers binding to the integrated 
complementary sequence. Barcode (BC) PCR was performed on genomic DNA. c, Meta-
analysis of mutagen integrations around transcriptional start sites (TSS) (excluding the 
precise TSS site). In particular Tol2 and Retrovirus show a preference to integrate in 
proximity to the TSS. Retroviruses also frequently integrate into the promotor regions, while 
lentiviral integrations are typically located within the entire gene body. IPKM= Insertions per 
kilobase per million. The vectors used are described in Fig. 1 legend. d, Distribution of 
integration sites. Binning the number of integrations in genic and 2kb upstream regions per 
10kb windows illustrates pronounced cold spots of mutagenesis using retroviral 
mutagenesis, where one can observe bins devoid of integrations. e, Genomic region 
surrounding the Gapdh locus exemplifying the distributions of integrations. While retroviral 
integrations strongly cluster, Tol2 displays a more uniform distribution of integration sites. 
Tracks are + strand (top) and – strand (bottom) integration sites. Bar lengths indicate NGS 
read numbers, subsequent to iPCR. f, Heat map illustrating overlap of epigenetic histone 
marks with integrations of the indicated mutagens, normalized to peak size. Only retrovirus 
and Tol2 integrations strongly correlate with DNA accessibility determined by ATACseq and 
active marks such as H3K4me3 and H3K27ac. In silico mutagenesis is shown as a control.  
 
Extended Data Figure 4. Insertional preferences and generation of mutant 
ES cell library.  
a, Correlation of integration probabilities (IPKM=insertions per kilobase per million) to 
expression level (mean log2 of FPKM). Strongest correlation is seen for lentiviral constructs 
as well as Retro-GT without osteopontin enhancer elements. All mutagenesis vectors are 
described in Fig. 1 and methods. b, 5’RACE on a set of pooled clones with confirmed antisense 
integration sites revealed multiple spurious transcription initiation sites in the intronic part 
of the gene trap vector around the lox site, but we failed to detect spliced transcripts. 
Transcriptional initiation within the lox5171 site is highlighted.  Red labelled sequence is 
marking polyGs used for 5’ tailing. c, Intersection of integration sites of the indicated 
mutagenesis vectors (see Fig. 1) with genomic features. Coding sequences (CDS), 5’ and 3’ 
untranslated regions (5’UTR and 3’UTR), 1st Intron, all other introns excluding the first 
intron (Intron), non-coding exons (ncExon), upstream regions (defined as 2kb upstream of 
transcriptional start site), and intergenic regions are indicated. Mutagenesis by Piggyback 
transposons as well as in silico random mutagenesis and ATACseq results are shown for 
comparison. d, Schematic work flow for generation of the mutant haploid ES cell library. 
Single cell derived clones were manually picked 10 or 11 days after seeding, expanded in 96 
well plates, and either frozen in quadruplicates or further processed for mapping of the 
integration sites. e, Schematic illustration of the first step of 4D pooling. Each plate was 
pooled into the respective slice tray as well as a master-plate, uniting identical well 
coordinates of all plates. f, Schematic illustration of the second step of 4D pooling. Each 
master-plate was pooled into a master tower pool, a plate with lamella uniting columns, and 
a plate with lamella uniting columns, thereby generating pools for rows and columns over all 
samples. g, 4-Dimensional pooling of 9600 clones in 8 rows, 12 columns, 10 slices, and 10 
towers resulting in 40 pools. Subsequent to iPCR to introduce experimental indices, pools 
were combined and deep sequenced. Amplification of internal barcodes confirmed clonal 
identity and mapping in 4 dimensions. All mapped clones were deposited to Haplobank 
(www.haplobank.at).  
 
Extended Data Figure 5. Numbers of independent gene trap clones and 
intragenic distribution. 
a, Numbers of independent available cell lines, carrying a single integration per cell, per gene. 
For about 37% (RefSeq) to 38% (Ensembl) of genes targeted, there is one gene trap clone 
available (5’UTR, Intron, or coding sequence), whereas about 18% of genes are targeted in 
two independent clones, and for ~ 43% of genes 3 or more independent clones are available. 
b, 24.8% (RefSeq) to 26.8% (Ensembl) of genes are represented by a single cell line if one 
takes all clones into account and about 40% of genes are hit in more 3 or more clones. c, 
Separation of all gene traps combined into biotypes in single integration Haplobank clones. 
Antisense and intergenic insertions are observed in all systems, in particular for enhanced 
gene trap vectors. d, To map the integration sites of our Haplobank clones to the ORFs (open 
reading frames) of the respective genes dissected ORFs into 5% intervals and annotated 
integration sites in introns and exons relative to the position within the ORF. All mutagenesis 
systems (see Fig. 1) show a strong bias towards transcript truncation proximal to the 5’end 
of the ORFs and are thus predicted to result in loss of function alleles. We defined integrations 
in the anterior 50% of coding sequence (green bars) as optimal for a gene trap allele; these 
clones are highlighted by a yellow star on the Haplobank homepage.  
 
Extended Data Figure 6. Interaction of Pla2g16 with Cox inhibitors in 
mouse ES cells.  
a, Titration series of the indicated Cox inhibitors in the presence and absence of rhinovirus 
(RV-A1a) in mouse ES cells. No protective effect of inhibition of prostaglandin biosynthesis 
was detected at non-toxic concentrations. Since ES cells do not generate infectious RV-A1a 
efficiently, conditioned supernatant containing RV-A1a was added daily. Data is shown as 
individual data points and mean values. b, Haplobank ES cell clones harboring mutations in 
Ldlr and Pla2g16, respectively, were mixed as sister cells in sense (red) and antisense (green) 
orientation labelled by GFP and mCherry. Subsequently, cells were cultured in the presence 
and absence of rhinovirus RV-A1a for 4 days and ratios were then quantified using FACS. 
Selection pressure for loss of Ldlr and Pla2g16 was not affected by inhibition of Cox. Data is 
shown as mean of 3 biological replicates, error bars represent SD. 
 Extended Data Figure 7. Interactions of PLA2G16 with Cox inhibitors in 
human HEK293T cells and domain mapping.  
a, RV-A1a exposure causes cell death in HEK293T cells in a dose dependent manner. Cell 
viability was quantified 3 days after infection by Alamar blue cell viability measurement. Data 
is shown as individual data points of 5 biological replicates and mean values. b, Titration 
series for ibuprofen and indomethacin treatment in the presence and absence of rhinovirus 
(RV-A1a) in human embryonic kidney HEK293T cells. Protective effects of ibuprofen and 
indomethacin were detected at high concentration. Cell viability was quantified 2.5 days after 
infection by Alamar blue cell viability measurement. Data is shown as individual data points 
of 4 biological replicates and mean values. c, Competitive growth assays in HEK293T cells. 
Cells containing sgRNAs targeting  PLA2G16 did not show a growth difference in the absence 
of RV-A1a or when treated with indomethacin at 100M, but were significantly enriched 
when challenged with RV-A1a, indicting preferential survival. By contrast, control guide 
treated cells did not show growth advantages at any experimental condition. Data are shown 
as individual data points and mean values +/- SD of biological triplicates analysed on days 0, 
3, 6, and 10 after RV-A1a exposure. d, Scheme of Pla2g16 domains. The enzymatic center of 
Pla2g16 is located in the cytoplasm (green); an alpha-helix in the transmembrane domain 
(yellow) connects it to a short vesicular domain (blue), located in endosomes49. e, Design of 
CRISPR sgRNAs targeting the mRNA regions encoding the vesicular domain of 7 amino acids 
(sgRNA1) and the 3’UTR (sgRNA2) in haploid ES cells to test essentiality of these domains in 
RV-A1a infections. f, Cells carrying sgRNA2 showed editing in only 1/12 cases, but upon 
selection with RV-A1a were enriched for deletions within the vesicular domain. For sgRNA2, 
all mapped deletions in control cells only affected the 3’UTR, where the expected Cas9 cuts 
occur; upon RV-A1a exposure, the majority of observed deletions affected the 
transmembrane domain, the vesicular domain, and in some cases even extended into the 
cytoplasmatic region. Color codes: Grey: deletion; Red: alternative reading frame and 
insertions.  
 
Extended Data Figure 8. Blood vessel sprouting in Notch1 mutant ES cells 
and candidate tip cell genes.  
a, Assessment of 4 independent Notch1 targeted clones from Haplobank. The locations of the 
integrations are shown: 2 anti-sense (as) clones marked by green triangles, 1 sense (s) clone 
marked by the red triangle, and one clone with an upstream (as-up) integration (blue 
triangle). Flipping of the gene traps upon Cre infection is shown by PCR in the middle panel. 
Loss of Notch1 protein (intracellular domain, ICD) expression (clones A4, H7), and re-
expression (clone D5) upon Cre recombination are shown by Western blot (lower panel). -
actin is shown as a loading control. WT, parental clone without any gene trap integration. 
Uncropped blots are shown in Supplementary Figure 1. b, Notch1 inactivation leads to a 
hyper-sprouting phenotype. Note the advanced progression and increased density of the 
vascular networks upon Notch1 deletion (sense clone) compared to anti-sense sister cells 
(upper panels – bright field images, lower panels IB4 immunostaining to mark endothelial 
cells). Scale bars 500µm. c, Angiogenic sprouting is not affected when the gene trap is located 
1500bp upstream of the Notch1 gene (A2 clone). For molecular characterization of the A2 
clone see Extended Data Fig. 12. GFP+ and Cre-reverted mCherry+ sister cells were analyzed 
in 3D blood vessel organoid cultures. Bright field images are shown. Scale bars 500 µm. d, 
Differentially expressed genes in endothelial tip cells versus stalk cells from two published 
datasets30,31 in the murine retina were filtered for genes that have also been associated 
(Ingenuity pathway analysis) with candidate genes/pathways for vascular diseases in 
humans. Scatterplot showing the frequency of independent associations of “tip cell genes” 
with various human vascular diseases. Genes available at Haplobank at the beginning of the 
project were chosen for functional analysis in the 3D organoids. For most of the listed 
candidate genes, there were no functional vascular data available. e, Quantification of IB4 
positive vascular structures from the indicated sister clones carrying sense and repaired 
antisense integrations. Clones were classified according to their sprouting capacity from low 
(hypo-sprouting) to high (hyper-sprouting).Data are shown as individual data points from a 
minimum of n=3 independent experiments for each sense/antisense sister clone 
combination together with the mean values ± SEM. * P < 0.05; ** P < 0.01; *** P < 0.001 (Two 
tailed students t-test). f, Different clones with independent integrations in the same gene 
showed reproducible phenotypes in sprouting angiogenesis. Vascular outgrowths were 
stained for endothelial specific IB4 expression, number of vessels counted and normalized to 
the respective anti-sense sister clones. Data are shown as individual data points from a 
minimum of n=3 independent experiments for each sense/antisense sister clone 
combination together with the mean values ± SEM. * P < 0.05; ** P < 0.01; *** P < 0.001 (Two 
tailed students t-test).  
 
Extended Data Figure 9. Sprouting angiogenesis in revertible sister clones.  
Representative images of the indicated sense (S) and anti-sense (AS) sister clones. IB4 was 
used to mark endothelial cells. GFP or mCherry expression indicates the respective flipped 
gene traps. Note that some sense clones are GFP+ while others are mCherry+; this is due to 
the original orientation of the integration in sense or anti-sense, which was then reverted by 
the mCherry-Cre expressing virus. Scale bars for all images is 500µm. For quantification of 
data see Fig. 3e.  
 
Extended Data Figure 10. Generation of a chimeric vasculature in vivo and 
Gja1/Connexin43 localization to tip cells  
a, Representative fluorescence image of a haploid ES cell-derived teratoma stained for 
endothelial specific IB4. Endothelial cells arising from haploid ES cells are positive for 
mCherry and IB4 (yellow), whereas host endothelial cells are only positive for IB4 and 
appear green. Scale bars 50 µm. b, Representative FACS analysis of teratomas following 
injection of chimaeric EBs into immunocompromised mice. Myst3 anti-sense (mCherry+) 
and sense (GFP+) sister clones were mixed at a 1:1 ratio. VE-Cadherin-negative non-
endothelial cells were also determined within the teratomas. c, Parental haploid ES cells 
stably expressing GFP or mCherry-Cre were assessed for their ability to generate IB4+ 
vascular structures in the presence of VEGF-A. The number and ratios of IB4+ vessels per 
organoid were not apparently different between GFP and mCherry-Cre expressing cells. 
Scale bars 500µm. Data are shown as individual data points from n=4 independent 
experiments mean values ± SEM. P=0.207 (Two tailed students t-test). d, GFP and 
mCherry-Cre expressing parental haploid ES cells contribute equally to tip cells (49.2 % 
GFP+; 50.8 % mCherry-Cre+) in 1:1 mixed mosaic cultures. Data are shown as individual 
data points from of n=4 independent experiments together with the mean values ± SEM. 
P=0.823 (Two tailed students t-test). e, Localization of Gja1/Connexin43 protein in the 
murine retina at postnatal day 6 (P6). Endothelial cells are marked by IB4 staining. At the 
angiogenic front, Gja1/Connexin43 expression is found in endothelial cells, primarily 
localized at tip cells (arrows). Scale bars 50µm. f, Retinas were stained for 
Gja1/Connexin43 protein expression and the endothelial marker IB4 to visualize the 
vascular networks on postnatal day 6 (P6). Note punctate pattern of Gja1/Connexin43 
adjacent to the IB4+ vessels, suggestive of Gja1/Connexin43 expression in perivascular 
cells. Scale bars 50 µm. g, Gja1/Connexin43 protein predominantly localizes to the tip cells 
(arrows) in the 3D blood vessels. Vessels are marked by CD31 immunostaining and 
counterstained by DAPI. Bar graph indicates percentages of vessels with highest 
Gja1/Connexin43 expression in the tip cell; Data is shown as individual data points of 8 
independent EBs together with the mean values ± SD of vessels. Scale bars upper panels 
20µm, lower panels 10µm. 
 
